PET imaging shows various AD features: FDG-PET hypometabolism in temporoparietal regions with moderate decline, limbic atrophy, and tau uptake, especially in the entorhinal cortex, which indicates tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.